Background illustration for clinical trials search

Paid Clinical Trials Denver

Discover 1,569 paid clinical trials in Denver, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

for
Ornithine Transcarbamylase Deficiency,
Location: Aurora CO, New York NY
Sponsor: iECURE, Inc.

Sex: All

Age: 0 - 1

Code: NCT06805695

Recruiting
Active & Responsive

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

for
Cytomegalovirus Prophylaxis
Location: Aurora CO, Minneapolis MN, Rochester MN, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07199465

Phase 1, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Denver CO, Salt Lake City UT, Omaha NE, Kansas City MO,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase 3, Recruiting
Active & Responsive

Pediatric Post-Approval Registry

for
Obstructive Sleep Apnea
Location: Aurora CO, Dallas TX, Cincinnati OH, Sewickley PA,
Sponsor: Inspire Medical Systems, Inc.

Sex: All

Age: 18 - 21

Code: NCT04457154

Recruiting
Active & Responsive

Danon Disease Natural History Study

for
Danon Disease
Location: Aurora CO, Phoenix AZ, Dallas TX, St Louis MO,
Sponsor: Rocket Pharmaceuticals Inc.

Sex: All

Age: 8+

Code: NCT06214507

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Aurora CO, Phoenix AZ, Rochester MN, Iowa City IA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase 2, Recruiting
Active & Responsive

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

for
Influenza, Human
Location: Aurora CO, Colorado Springs CO, Santa Fe NM,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65+

Code: NCT07805707

Phase 3, Recruiting
Active & Responsive

Global Paradise System US Post Approval Study

for
Hypertension, Cardiovascular Diseases, Vascular Diseases
Location: Aurora CO, Loveland CO, Salt Lake City UT, Wichita KS,
Sponsor: ReCor Medical, Inc.

Sex: All

Age: 18+

Code: NCT06297291

Recruiting
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase 3, Recruiting
Active & ResponsiveNew

Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans

for
Overweight/Obesity, Stress
Location: Aurora CO
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT06627569

Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: Aurora CO, Kansas City MO, Boise ID, Minneapolis MN,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase 2, Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Aurora CO, Albuquerque NM, Billings MT, Phoenix AZ,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase 3, Recruiting
Active & Responsive

EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety

for
Alport Syndrome, X-Linked, Alport Syndrome, Autosomal Recessive
Location: Denver CO
Sponsor: Eloxx Pharmaceuticals, Inc.

Sex: All

Age: 12+

Code: NCT07523581

Phase 2, Recruiting
Active & Responsive

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

for
Relapsing Multiple Sclerosis,
Location: Aurora CO, Dallas TX, Rochester MN, St Louis MO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT04047628

Phase 3, Recruiting
Active & ResponsiveNew

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Aurora CO, Salt Lake City UT, El Paso TX, Phoenix AZ,
Sponsor: Kallyope Inc.

Sex: All

Age: 18 - 70+

Code: NCT07816367

Phase 3, Recruiting
Active & Responsive

A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

for
Lumbar Disc Disease
Location: Greenwood Village CO, Austin TX, Santa Monica CA,
Sponsor: BioRestorative Therapies

Sex: All

Age: 18+

Code: NCT04042844

Phase 2, Recruiting
Active & Responsive

Collaborative Care for Treatment of Depression and Anxiety

for
Depression, Anxiety
Location: Aurora CO
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT06556589

Recruiting
Active & Responsive

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Golden CO, Greeley CO, Loveland CO, Fort Collins CO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase 3, Recruiting
Active & Responsive

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for
Non-small Cell Lung Cancer, NSCLC
Location: Golden CO, Grand Junction CO, Albuquerque NM,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06422143

Phase 3, Recruiting
Active & Responsive

Using CTA Measures to Define Cardiac Risk In NFL Alumni

for
Coronary Artery Disease (CAD), Heart Disease,
Location: Greenwood Village CO
Sponsor: HeartFlow, Inc.

Sex: All

Age: 0+

Code: NCT06831409

Recruiting

Denver is a pivotal hub for clinical trials, thanks to its sturdy healthcare network and renowned medical research institutions. Prominent centers such as the University of Colorado Anschutz Medical Campus, Denver Health, and Children’s Hospital Colorado are at the forefront of groundbreaking studies focusing on areas including cancer research, neurological disorders, and chronic diseases.

Denver's strong emphasis on collaboration among healthcare providers, researchers, and community organizations fosters an environment conducive to medical advancements. By participating in clinical trials in Denver, individuals not only gain access to cutting-edge therapies but also contribute significantly to the progress of medical science.

Why choose Denver for clinical trials?

Denver boasts a diverse population which helps increase the reliability and relevance of research outcomes. The city is also home to top-tier medical research facilities known for innovative approaches to healthcare and a strong emphasis on medical breakthroughs.

Choosing to participate in a clinical trial in Denver means contributing to vital medical research while benefiting from a well-coordinated and supportive clinical research infrastructure. This environment not only promotes advancements in medical science but also provides participants with access to pioneering therapies and specialized care throughout the study.

Common conditions studied in Denver

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Denver